PDE inhibitors have been identified as promising therapeutic agents for the treatment of AD [114,115,119] since, as reported above, cAMP and cGMP signalling are crucial for memory formation and consolidation. The gene discussed is ALDH7A1; the disease is Alzheimer disease.